KalVista Pharmaceuticals, Inc. (KALV)

19.28 -0.15 (-0.77%) USD  |  NASDAQ  |  Apr 22, 15:42
More

KalVista Pharmaceuticals Consensus Recommendation

Consensus Recommendation Chart

View Consensus Recommendation for KALV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Consensus Recommendation Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Consensus Recommendation Range, Past 5 Years

View Consensus Recommendation Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Consensus Recommendation Benchmarks

View Consensus Recommendation Benchmarks
Start Trial
Intellia Therapeutics, Inc. Upgrade
Recursion Pharmaceuticals, Inc. Upgrade
Tango Therapeutics, Inc. Upgrade
Modular Medical, Inc. Upgrade
Iovance Biotherapeutics, Inc. Upgrade